Pharmacoeconomics: Open Access
Pharmacoeconomics deals with systematic studies on cost and outcomes of pharmaceutical products and services. The Journal disseminates scholarly knowledge on a wide array of topics within the purview of health economics including cost minimization and cost-benefit analysis. The Journal focuses on promulgating systematically generated knowledge from pharmacoeconomic evaluation methods having substantial implication on patient care and health-associated quality of life. The Journal publications provide reliable and practical knowledge resources to healthcare providers and clinical decision makers in improving patient outcome. Ever since the establishment in the year 2016, the Journal has produced five volumes of peer-reviewed articles with an issue release frequency of two per year. In the preceding year, the Journal has published a total of seven articles that included original research and reviews on economic impact of COVID-19 patient management, cost of reusable duodenoscopes, adverse effects of anti-tubercular drug medication, role of vaccine for preventing recurrent respiratory tract infection in immunodeficient patients, role of traditional medicine among HIV infected people and drug characterization. These articles were contributed by 14 authors from different countries. Interested authors can submit their manuscripts at https://www.scholarscentral.org/submissions/pharmaceutical-economics-policy-studies.html or send as an e-mail attachment to the Editorial Office at editor@hilarispublisher.com. Authors can access further instructions and guidelines at https://www.hilarispublisher.com/pharmacoeconomics-open-access/instructionsforauthors.html. The Journal offers customized benefits to the authors that include language translation and editing services, fast tracked editorial processing, post-production promotion of the published article and online tracking of the manuscript processing progress. t
82 views • 4 slides
